Digital health accelerator PharmStars recently celebrated the successful completion of its spring 2023 cohort, focusing on "Innovations in Women's Health or Health Equity."
After a rigorous selection process, 13 startups were chosen from a pool of over 60 applicants representing 14 countries. These startups offered unique digital health solutions, ranging from novel biomarkers to diagnostic tools and digital therapeutics.
The cohort underwent PharmStars' comprehensive 10-week program, PharmaU, which concluded with a showcase event held in Boston in May. During this event, participating startups had the opportunity to engage in one-on-one meetings with influential pharmaceutical companies like Roche, Pfizer, and Novo Nordisk, all members of the PharmStars network.
PharmStars is now actively seeking applications for its upcoming fall cohort, centred around the theme of "Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface." Digital health startups interested in joining this transformative program can access further information and the application form on the PharmStars website. The application deadline is set for July 10th.
Click here to read the original news story.